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This paper describes the antioxidant effects of thirteen phenolic compounds isolated from plants of the genus Lychnophora. Two 
assays were performed to evaluate these effects: a cellular test that measured the luminol-enhanced chemiluminescence produced by 
neutrophils stimulated with opsonized zymosan and a cell-free test involving horseradish peroxidase-H2O2-luminol. In both assays, 
the antioxidant activity of the phenolic compounds was dependent on their concentration and chemical structure. Our results suggest 
that the ability of phenolic compounds from Lychnophora species to scavenge and inhibit the generation of ROS may be a mechanism 
underlying the anti-inflammatory activity of extracts from Lychnophora spp.
Keywords: antioxidant activity; Lychnophora; flavonoids.
INTRODUCTION
Neutrophils are often involved in tissue damage found in many 
inflammatory disorders, including rheumatoid arthritis, systemic lupus 
erythematosus, respiratory distress syndromes, blistering skin disorders 
and ulcerative colitis.1 Inflammation-induced tissue damage seems 
to depend on the ability of neutrophils to generate and release great 
amounts of reactive oxygen species (ROS), such as O2•- and HO•, and 
the highly reactive HOCl produced by myeloperoxidase.2 Excessive 
levels of ROS might overcome the endogenous antioxidant defense sys-
tem, leading to tissue injury that can amplify the inflammatory process.
Compounds with antioxidant activity have been used to prevent 
or alleviate tissue damage in inflammatory disorders.3,4 Phenolic 
compounds, especially flavonoids, have been studied as promising 
non-toxic antioxidants in various biological systems.5,6 Besides their 
antioxidant properties, such compounds have shown significant anti-
inflammatory effects.3
Phenolic compounds, such as flavonoids and cinnamic acid de-
rivatives, are commonly found in the Lychnophora genus (Vernoniae, 
Asteraceae). Other constituents that were already reported to some 
species from this genus are triterpenoids, steroids, sesquiterpene lac-
tones and lignans.7,8 Species of the Lychnophora genus are endemic 
in the Brazilian “campo rupestre,” a special kind of “cerrado” that 
exists at high altitudes. Lychnophora species are popularly known 
in Brazil as “arnica,” “falsa arnica,” or “arnica da serra”, and their 
hydroalcoholic preparations, obtained from the leaves, roots and 
inflorescences, are often used in folk medicine to treat inflamma-
tory disorders.9 Crude extracts or isolated compounds from these 
species have been reported to exhibit other pharmacological effects, 
such as antitumoral, molluscicidal, trypanocidal, anticonvulsant and 
analgesic activities.10,11 These different activities may be correlated 
with environmental conditions. Thus, variations in the total content 
and in the relative proportions of secondary metabolites in plants can 
modify the biological analysis and justifies the studies of series of 
natural products to define different contributions.12
The aim of the present study was to evaluate the inhibitory effect 
of thirteen phenolic compounds extracted from plants of the genus 
Lychnophora on ROS generation by stimulated neutrophils as well as 
their ROS scavenging properties in a cell-free system. The relationship 
between chemical structure and both biological effects is discussed.
EXPERIMENTAL
Plant material and isolated compounds 
The tested compounds [caffeic acid (1), vicenin-2 (2), galangin 
3-O-methyl (3), isorhamnetin 3-O-glucose (4), isorhamnetin 3-O-(6’’-
p-coumaroyl)-glucose (5), luteolin (6), pilloin (7), quercetin-3-O-me-
thyl (8), tectochrysin (9), tilliroside (10), pinobanksin (11), pinobanksin 
3-acetate (12) and pinocembrin (13)] were previously isolated from 
crude extracts of leaves plus inflorescences of L. gardneri Schultz-Bip 
(compound 10),13 L. staavioides Mart (compounds 2, 3, 8, 9, 11-13),10 
L. pohlii Schultz-Bip (compounds 1-9, 11, 12)14 and L. ericoides Mart 
(compound 2).15 L. ericoides was collected in Ibiraci (Minas Gerais 
State, Brazil) and the other plant material was collected in Diamantina 
(Minas Gerais State, Brazil), in July 1998. Voucher specimens of spice 
plant materials are deposited in the UEC Herbarium (Campinas, SP, 
Brazil): L. gardneri (Lopes456), L. staavioides (NPL212), L. pohlii 
(WV451) and L. ericoides (NPL122). The chemical structures of the 
isolated compounds are shown in Figure 1. The tests were performed 
at the time of isolation of phenolic compounds (2000-2002).
Chemicals
Luminol (5-amino-2, 3-dihydro-1, 4-phtalazinedione), Zymosan 
A, and Horseradish Peroxidase type VI-A (HRP) were purchased from 
Sigma-Aldrich (St. Louis, MO, USA). Dimethylsulfoxide (DMSO) 
and H2O2 were obtained respectively from Merck-Schuchardt (Ho-
henbrunn, Germany) and Labsynth (Diadema, SP, Brazil). All other 
chemicals were of the highest quality available. 
Isolation of rabbit neutrophils
Blood from adult New Zealand White female rabbits (weight 
about 3 kg) was collected from the central ear artery into Alsever 
solution (v/v) as anticoagulant. Neutrophils were isolated as des-
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cribed16 and suspended in Hanks Balanced Saline Solution (HBSS) 
containing gelatin 0.1% (w/v) (HBSS-gel) for use. The resulting cell 
preparations contained 80-90% of neutrophils, and more than 95% 
of these cells were viable, as determined by Trypan Blue exclusion.
ROS generation by stimulated neutrophils 
Antioxidant activity in the cellular system was evaluated accor-
ding to Lucisano-Valim et al..17 The concentration of each component 
in the reaction medium (1 mL) is indicated in parentheses below. 
Luminol (0.28 mmol/L) and aliquots of each test-compound (2.5 
-125 mmol/L) or DMSO (negative control) was added to neutrophil 
suspension (1 x 106 cells/mL), and the reaction mixture was incubated 
for 3 min at 37 oC. Afterwards, opsonized zymosan (OZ, 1 mg/mL) 
was added to the reaction tubes, which were carefully homogenized 
by inversion and transferred to the luminometer measuring chamber 
(Autolumat LB953, EG&G Bethold, Germany). Luminol and the 
tested compounds were dissolved in DMSO. Zymosan was prepared 
and opsonized with normal rabbit serum by the method of Cheung 
et al.,18 with slight modifications.6
The luminol-enhanced chemiluminescence (CL-lum) produced 
by the stimulated neutrophils was measured for 10 min at 37 ºC. The 
area under each CL-lum time course curve (AUC), also known as 
integrated area of CL-lum, was determined. These areas represent the 
total amount of ROS produced by the cells in 10 min. The method is 
more sensitive to ROS produced by the myeloperoxidase-H2O2-halide 
pathway. The inhibition of CL-lum promoted by each test-compound 
was calculated as follows: [1 - (AUC of studied compound / AUC of 
negative control)] x 100 (%).
ROS generation by cell-free system 
ROS-scavenging activity in cell-free system was evaluated ac-
cording to Krol et al.,19 with slight modifications. The concentration 
of each component in the reaction medium (1 mL) is indicated in 
parentheses below. Samples of each test-compound (0.01-1.0 mmol/L) 
or DMSO (control) were mixed with H2O2 (50 mmol/L) and luminol 
(0.28 mmol/L). The reaction was initiated by adding HRP (0.2 IU/
mL). CL-lum was measured for 10 min at 27 ºC. CL-lum inhibition 
was expressed as percentage, as described in the neutrophil test. 
Luminol and the tested compounds were dissolved in DMSO; H2O2 
and HRP were prepared in phosphate buffer (0.1 mol/L, pH 7.4).
Statistical analysis
The data were analysed by one-way analysis of variance (ANO-
VA) followed by the Tukey’s post-hoc test. The compared values were 
considered significantly different when P < 0.05. The analysis was 
performed using the GraphPad Prism software (GraphPad Software, 
San Diego, CA, USA).
RESULTS AND DISCUSSION
ROS generation by stimulated neutrophils
Immunomodulatory properties of the phenolic compounds isola-
ted from plants of the genus Lychnophora were assessed by inhibition 
of OZ-stimulated rabbit neutrophils oxidative metabolism, measured 
by the luminol-enhanced chemiluminescence assay
 
(Figure 2). Under 
our experimental conditions, compounds 6 and 8 were significantly 
more active than the other compounds tested, and compound 2 had 
no significant inhibitory activity, even at the highest concentration 
tested (125.0 μmol/L).
ROS generation by cell-free system
Free radical scavenging activity of the phenolic compounds isola-
ted from plants of the genus Lychnophora was evaluated by inhibition 
of chemiluminescence produced by HRP-catalyzed oxidation of 
luminol in the presence of H2O2 (Figure 3). In this assay, compounds 
6 and 8 were the most actives among the set of compounds tested, 
while compound 2 had no significant inhibitory activity, even at the 
Figure 1. Chemical structures of the phenolic compounds (1-13) isolated 
from Lychnophora species
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highest concentration tested (1.0 μmol/L). The course of CL-lum 
inhibition and its extent were similar in both tests, except for the 
phenolic acid 1, whose inhibitory activity in the cell-free system was 
higher than in the cellular test.
Due to their sensitivity and reproducibility, chemiluminescen-
ce (CL)-based assays have been widely used for monitoring ROS 
generation by enzymes, cells, and tissues.20 In the present study, a 
cellular and a cell-free luminol-enhanced chemiluminescence assays 
were used to evaluate the antioxidant and ROS scavenger effects, 
respectively, of thirteen phenolic compounds (Figure 1) isolated 
from Lychnophora species. The former involved rabbit neutrophils 
stimulated with particles of serum-opsonized zymosan and the later, 
a system composed of HRP-H2O2-luminol.18 The extent of inhibition 
was also similar in both tests, except for the phenolic acid 1, which 
had a higher inhibitory activity in the cell-free than in the cellular 
test. This result is particularly important, because 1 is one of the 
main metabolites of flavonoids produced by digestive enzymes and 
by microorganisms of the intestinal flora.21 The reported antioxidant 
effects were dependent on the concentration and chemical structure of 
the tested compounds. A structure-activity analysis is presented below. 
Being 5,7-dihydroxylated at ring A and having a catechol group at 
ring B, compounds 6 and 8 were the most active. Compound 3, which 
is structurally similar to 8 but lacks the catechol group, was less active 
than 8. This finding reinforces the hypothesis that the catechol group is 
important for antioxidant activity.5,22 Our results also support the idea 
that methoxy groups may enhance the antioxidant activity of phenolic 
compounds, since they increase the electronic density of the aromatic 
ring.23 Specifically, we observed that an additional methoxy group in 
R1 or R3 augmented the antioxidant activity, as can be observed by 
comparing 8 to 6 and 10 to 5, although significant differences of effect 
could be observed only at the lowest concentrations. On the other 
hand, chemical characteristics of ring B substituents had no influence 
on the activity of 7-methoxylated compounds 7 and 9. It thus seems 
that the position of the methoxy group is a major determinant of the 
antioxidant activity of flavonoids.
We observed that for compounds without C2-C3 double bond (11, 
12 and 13), the change of R2 from H (13) to OH (11) or ester (12) 
did not influence their ability to inhibit both the cellular and cell-free 
CL-lum. Similarly, in the case of the O-glycosylated flavonoids 4, 5, 
and 10, an increase of molecular volume of the group attached to R1 
(4 vs 5) did not influence the inhibitory activity. 
Information about structure-activity relationship comes also 
from 2, which had no effect on ROS generation by the cellular and 
cell-free systems under the assessed conditions. This compound has 
Figure 2. Effects of phenolic compounds (2.5-125.0 mmol/L) isolated from 
Lychnophora species on ROS generation by opsonized zymosan-stimulated 
rabbit neutrophils. Compounds 1-5 (A), 6-10 (B) and 11-13 (C) were shown 
separately for a better visualization of their concentration-dependent inhibi-
tory effects. Values are shown as mean ± SD of the inhibition (%) of CL-lum 
of three independent experiments. *Significant difference (p < 0.05) from 
DMSO-treated controls (negative control)
Figure 3. Effects of phenolic compounds (0.01-1.0 mmol/L) isolated from 
Lychnophora species on ROS generation by HRP-H2O2-luminol chemilumi-
nescence system. Compounds 1-5 (A), 6-10 (B) and 11-13 (C) were shown 
separately for a better visualization of their concentration-dependent inhibi-
tory effects. Values are shown as mean ± SD of the inhibition (%) of CL-lum 
of three independent experiments. *Significant difference (p < 0.05) from 
DMSO-treated controls
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C-glycosidic groups attached to positions 6 or 8 of the A ring, which 
could promote steric hindrance and impair ROS interaction with 
the hydroxy group of this ring. This reinforces that, as previously 
discussed, these interactions determine the antioxidant activity of 
flavonoids. It may thus seem that antioxidant properties are largely 
reduced in glycosylated flavonoids, the predominant natural form 
of flavonoids. In general, glycosylation increases hydrophilicity of 
a molecule, which in its turn impairs its interaction with cellular 
membranes and decreases its rate of absorption.5 However, one must 
consider that in more complex organisms, gastrointestinal or bacterial 
enzymes removes the sugar moiety from flavonoid glycosides, making 
their aglycone forms available to be absorbed by the gut.24
The flavonoids 10 and 13 showed marked anti-inflammatory 
activity in vivo in previous studies.25 Considering the involvement 
of ROS in the inflammatory process, we suggest that the antioxidant 
activity of these compounds found in the present work (Figures 2 and 
3) may be a mechanism underlying their anti-inflammatory effect 
reported previously.
In summary, the inhibitory effect of the studied polyphenolic 
compounds on ROS generation by different systems was dependent 
on their concentration and chemical structures. The ROS-scavenging 
activity of these compounds, as evaluated by the cell-free system 
HRP-H2O2-luminol, could be one of the mechanisms responsible for 
inhibition of CL-lum produced by opsonized zymosan-stimulated 
neutrophils. Other mechanisms could also be involved, such as inhi-
bition of enzymes that participate in ROS generation in neutrophils, 
such as NADPH oxidase, phosphoinositide 3-kinase g, and myelo-
peroxidase.26 Therefore, further studies are necessary to elucidate the 
mechanisms of action of these compounds and the CL-lum studies 
as reported here thus serve as stepping stone for more in-depth in-
vestigations of the drug-neutrophil interactions. 
CONCLUSION
The antioxidant activity of phenolic compounds is highly de-
pendent on their chemical structures. The presence of a catechol 
group and the extended conjugation in the caffeic acid molecule may 
contribute to its antioxidant activity. Regarding the flavonoids, some 
requirements may determine or increase the antioxidant activity: 
ortho-dihydroxy group in ring B; hydroxyl at C-4’; unsaturation 
between C-2 and C-3 in conjunction with the carbonyl at C-4 (ring 
C); hydroxyl at C-3 and C-5. Furthermore, the ability of phenolic 
compounds from Lychnophora species to scavenge and inhibit 
the generation of ROS may be a mechanism underlying the anti-
inflammatory activity of hydroalcoholic extracts of many species 
from Lychnophora genus, which are used in Brazilian folk medicine. 
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